These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30946934)

  • 1. A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma.
    Gupta S; Sosa CP; Kosari F; Folpe A; Bhinge KN; Yang L; Agahi A; Johnson SH; Frank I; Boorjian SA; Hansel DE; Al-Ahmadie HA; Reuter VE; Vasmatzis G; Jimenez RE; Herrera-Hernandez L; Cheville JC
    Hum Pathol; 2019 Jun; 88():48-59. PubMed ID: 30946934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.
    Bahrami A; Gown AM; Baird GS; Hicks MJ; Folpe AL
    Mod Pathol; 2008 Jul; 21(7):795-806. PubMed ID: 18487991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult urinary bladder tumors with rhabdomyosarcomatous differentiation: clinical, pathological and immunohistochemical studies.
    Bing Z; Zhang PJ
    Diagn Pathol; 2011 Jul; 6():66. PubMed ID: 21762516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications.
    Akbulut D; Whiting K; Teo MY; Tallman JE; Ozcan GG; Basar M; Jia L; Rammal R; Chen JF; Sarungbam J; Chen YB; Gopalan A; Fine SW; Tickoo SK; Mehra R; Baine M; Bochner BH; Pietzak EJ; Bajorin DF; Rosenberg JE; Iyer G; Solit DB; Reuter VE; Rekhtman N; Ostrovnaya I; Al-Ahmadie H
    Mod Pathol; 2024 Oct; 37(10):100557. PubMed ID: 38964503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report.
    Kamei M; Shinohara T; Kasahara K; Kuno T; Naruse K; Watanabe H
    J Med Case Rep; 2015 Sep; 9():199. PubMed ID: 26358638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Helpap B
    Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-urothelial tumors of the urinary tract].
    Mikuz G
    Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E; Garg K; Stohr BA
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cell neuroendocrine carcinoma and poorly differentiated rhabdomyosarcomas of the urinary bladder in adults-A comparative analysis in favor of a common histogenesis.
    Bahlinger V; Stoehr R; Hartmann A; Hes O; Agaimy A
    Virchows Arch; 2024 Oct; 485(4):615-623. PubMed ID: 38833173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
    Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
    Folpe AL; McKenney JK; Bridge JA; Weiss SW
    Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of the neural development transcription factors (TTF1, ASCL1 and BRN2) in neuroendocrine prostate tumours.
    Rodríguez-Zarco E; Vallejo-Benítez A; Umbría-Jiménez S; Pereira-Gallardo S; Pabón-Carrasco S; Azueta A; González-Cámpora R; Espinal PS; García-Escudero A
    Actas Urol Esp; 2017 Oct; 41(8):529-534. PubMed ID: 28285791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification.
    Cordes B; Williams MD; Tirado Y; Bell D; Rosenthal DI; Al-Dhahri SF; Hanna EY; El-Naggar AK
    Hum Pathol; 2009 Mar; 40(3):283-92. PubMed ID: 19150107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Utility of GATA3 in the Diagnosis of Urothelial Carcinomas With Variant Morphologic Patterns.
    Verduin L; Mentrikoski MJ; Heitz CT; Wick MR
    Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):509-13. PubMed ID: 26317312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases.
    Wang G; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2018 Sep; 79():57-65. PubMed ID: 29763719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.